NIW Approved for Clinical Medicine Researcher Advancing Cost-Efficient and Impactful Healthcare Solutions

Posted by wegreened on August 16, 2025 in NIW, General Medicine (Public Health, Clinical Research, Infectious Diseases, Vaccines, Virology, Epidemiology, Clinical Psychology, Psychiatry)

Client’s Testimonial:

“I had a great experience with my lawyer. Everything was done meticulously, with personalized advice, and on time. I think it was totally worth getting Chen's services.”

On March 12^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Clinical Research Coordinator in the Field of Clinical Medicine (Approval Notice).

General Field: Clinical Medicine

Position at the Time of Case Filing: Clinical Research Coordinator

Country of Origin: Pakistan

State of Residence at the Time of Filing: Ohio

Approval Notice Date: March 12^th, 2025

Processing Time: 1 month, 14 days (Premium Processing)

Case Summary:

We are excited to announce the NIW approval of a clinical researcher from Pakistan, whose groundbreaking work addresses one of the most pressing needs in the U.S. healthcare system: optimizing cost-efficiency and improving patient outcomes. At the time of filing, the client was conducting advanced clinical research at a major U.S. medical center, with a focus on analyzing patient data and clinical literature to improve healthcare delivery through evidence-based strategies.

His proposed endeavor centers on identifying scalable solutions to reduce patient morbidity and mortality, particularly in the management of chronic diseases. This research is critical to enhancing healthcare quality while reducing waste, aligning perfectly with national policy goals such as expanding value-based care initiatives.

Transforming Healthcare Efficiency and Outcomes

The client’s work directly targets inefficiencies in healthcare spending and delivery. By synthesizing large-scale clinical datasets and published studies, his research supports:

● Evidence-driven clinical decision-making ● Reduction of preventable mortality ● Scalable implementation of cost-saving interventions ● Integration of artificial intelligence into healthcare analytics

These efforts not only enhance care for individuals with chronic conditions but also contribute to broader system-wide improvements, as the U.S. strives to expand value-based care coverage to most Medicare and Medicaid beneficiaries by 2030.

Research Impact and Professional Recognition

To demonstrate the client’s influence in the field, we submitted detailed evidence including:

● 13 peer-reviewed journal articles and 2 abstracts ● 395 citations to date, including 2 papers in the top 1%, 1 in the top 10%, and 3 in the top 20% most cited articles for their year and field ● Regular peer reviewer for at least 7 clinical journals, with over 35 completed reviews

His work has been cited in studies published across neuroscience, orthopedics, AI in pandemic response, and medical education. These citations underscore his recognized authority and confirm that fellow researchers are using his findings to advance their projects in diverse medical domains.

National Benefit and Policy Alignment

In framing our legal argument, we emphasized how this research aligns with U.S. goals to improve healthcare efficiency, reduce preventable deaths, and incorporate AI into clinical settings. His work is in line with critical and emerging technology (CET) initiatives as recognized by the National Science and Technology Council, and it supports U.S. competitiveness and technological leadership in medicine.

We also demonstrated that waiving the job offer and labor certification requirements would be beneficial to the United States, given the unique expertise, proven success, and public health relevance of his contributions.

Approval and Outcome

Filed in January 2025 and approved in March 2025, this NIW petition was adjudicated through direct premium processing in just over six weeks. The case highlights the client’s commitment to research that directly improves U.S. healthcare systems, while showcasing NAILG’s continued success in guiding high-impact clinical professionals through the NIW process.

We are proud to support this client and look forward to seeing the continued impact of his vital work on national healthcare outcomes.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Sixty-four Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2012.01 - 2025.12)

Category	Approval or Refund^®		Approval or Refiling^TM
	Approval or Refund^®
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	42,047	99%	5,258	97%
EB1A	9,218	91%	4,534	86%
EB1B	1,488	98%	448	93%
Total	52,753	98%	10,240	92%